------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The amount of blood surgical patients can donate and store before surgery can be increased by the new genetically
    engineered drug, EPO.

Treebanked sentence:
--------------------
    The amount of blood 0 surgical patients can donate and store *T*-1 before surgery can be increased *-3 by the new
    genetically engineered drug , EPO .

Tree:
-----
    (TOP (S (NP-SBJ-3 (NP (DT The)
                          (NN amount))
                      (PP (IN of)
                          (NP (NP (NN blood))
                              (SBAR (WHNP-1 (-NONE- 0))
                                    (S (NP-SBJ (JJ surgical)
                                               (NNS patients))
                                       (VP (MD can)
                                           (VP (VB donate)
                                               (CC and)
                                               (VB store)
                                               (NP (-NONE- *T*-1))
                                               (PP-TMP (IN before)
                                                       (NP (NN surgery))))))))))
            (VP (MD can)
                (VP (VB be)
                    (VP (VBN increased)
                        (NP (-NONE- *-3))
                        (PP (IN by)
                            (NP-LGS (NP (DT the)
                                        (JJ new)
                                        (ADJP (RB genetically)
                                              (VBN engineered))
                                        (NN drug))
                                    (, ,)
                                    (NP (NNP EPO)))))))
            (. .)))

Leaves:
-------
    0   The
    1   amount
    2   of
    3   blood
    4   0
    5   surgical
    6   patients
    7   can
    8   donate
           sense: donate-v.1
           prop:  donate.01
            v          * -> 8:0,  donate
            ARG0       * -> 5:1,  surgical patients
            ARGM-MOD   * -> 7:0,  can
            ARG1       * -> 11:0, *T*-1 -> 4:0, 0
            ARGM-TMP   * -> 12:1, before surgery
            LINK-SLC   * -> 3:1,  blood
                       * -> 11:0, *T*-1 -> 4:0, 0
    9   and
    10  store
           sense: store-v.1
           prop:  store.01
            v          * -> 10:0, store
            ARG0       * -> 5:1,  surgical patients
            ARGM-MOD   * -> 7:0,  can
            ARG1       * -> 11:0, *T*-1 -> 4:0, 0
            ARGM-TMP   * -> 12:1, before surgery
            LINK-SLC   * -> 3:1,  blood
                       * -> 11:0, *T*-1 -> 4:0, 0
    11  *T*-1
    12  before
    13  surgery
    14  can
    15  be
    16  increased
           sense: increase-v.1
           prop:  increase.01
            v          * -> 16:0, increased
            ARGM-MOD   * -> 14:0, can
            ARG1       * -> 17:0, *-3 -> 0:2, The amount of blood 0 surgical patients can donate and store *T*-1 before
                                              surgery
            ARG0       * -> 18:1, by the new genetically engineered drug , EPO
    17  *-3
    18  by
    19  the
    20  new
    21  genetically
    22  engineered
           prop:  engineer.01
            v          * -> 22:0, engineered
            ARGM-MNR   * -> 21:0, genetically
            ARG1       * -> 23:0, drug
    23  drug
    24  ,
    25  EPO
    26  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    EPO, or erythropoietin, is a protein the human body makes to stimulate the growth of red blood cells.

Treebanked sentence:
--------------------
    EPO , or erythropoietin , is a protein 0 the human body makes *T*-1 *PRO*-2 to stimulate the growth of red blood cells .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP EPO))
                    (, ,)
                    (CC or)
                    (NP (NN erythropoietin))
                    (, ,))
            (VP (VBZ is)
                (NP-PRD (NP (DT a)
                            (NN protein))
                        (SBAR (WHNP-1 (-NONE- 0))
                              (S (NP-SBJ-2 (DT the)
                                           (JJ human)
                                           (NN body))
                                 (VP (VBZ makes)
                                     (NP (-NONE- *T*-1))
                                     (S-PRP (NP-SBJ (-NONE- *PRO*-2))
                                            (VP (TO to)
                                                (VP (VB stimulate)
                                                    (NP (NP (DT the)
                                                            (NN growth))
                                                        (PP (IN of)
                                                            (NP (JJ red)
                                                                (NN blood)
                                                                (NNS cells))))))))))))
            (. .)))

Leaves:
-------
    0   EPO
    1   ,
    2   or
    3   erythropoietin
    4   ,
    5   is
           prop:  be.01
            v          * -> 5:0,  is
            ARG1       * -> 0:2,  EPO , or erythropoietin ,
            ARG2       * -> 6:2,  a protein 0 the human body makes *T*-1 *PRO*-2 to stimulate the growth of red blood
                                  cells
    6   a
    7   protein
    8   0
    9   the
    10  human
    11  body
    12  makes
           prop:  make.01
            v          * -> 12:0, makes
            ARG0       * -> 14:0, *PRO*-2 -> 9:1, the human body
            ARG1       * -> 13:0, *T*-1 -> 8:0, 0
            ARGM-PRP   * -> 14:2, *PRO*-2 to stimulate the growth of red blood cells
            LINK-SLC   * -> 6:1,  a protein
                       * -> 13:0, *T*-1 -> 8:0, 0
    13  *T*-1
    14  *PRO*-2
    15  to
    16  stimulate
           sense: stimulate-v.1
           prop:  stimulate.01
            v          * -> 16:0, stimulate
            ARG0       * -> 14:0, *PRO*-2 -> 9:1, the human body
            ARG1       * -> 17:2, the growth of red blood cells
    17  the
    18  growth
    19  of
    20  red
    21  blood
    22  cells
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A genetically engineered version of the human protein developed by Amgen Corp. of Thousand Oaks, Calif., recently has
    been marketed by the Ortho Pharmaceuticals division of Johnson & Johnson.

Treebanked sentence:
--------------------
    A genetically engineered version of the human protein developed * by Amgen Corp. of Thousand Oaks , Calif. , recently
    has been marketed *-1 by the Ortho Pharmaceuticals division of Johnson & Johnson .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NP (NP (DT A)
                              (ADJP (RB genetically)
                                    (VBN engineered))
                              (NN version))
                          (PP (IN of)
                              (NP (DT the)
                                  (JJ human)
                                  (NN protein))))
                      (VP (VBN developed)
                          (NP (-NONE- *))
                          (PP (IN by)
                              (NP-LGS (NP (NNP Amgen)
                                          (NNP Corp.))
                                      (PP (IN of)
                                          (NP (NP (NNP Thousand)
                                                  (NNP Oaks))
                                              (, ,)
                                              (NP (NNP Calif.))
                                              (, ,)))))))
            (ADVP-TMP (RB recently))
            (VP (VBZ has)
                (VP (VBN been)
                    (VP (VBN marketed)
                        (NP (-NONE- *-1))
                        (PP (IN by)
                            (NP-LGS (NP (DT the)
                                        (NML (NNP Ortho)
                                             (NNP Pharmaceuticals))
                                        (NN division))
                                    (PP (IN of)
                                        (NP (NNP Johnson)
                                            (CC &)
                                            (NNP Johnson))))))))
            (. .)))

Leaves:
-------
    0   A
    1   genetically
    2   engineered
           prop:  engineer.01
            v          * -> 2:0,  engineered
            ARGM-MNR   * -> 1:0,  genetically
            ARG1       * -> 3:0,  version
    3   version
    4   of
    5   the
    6   human
    7   protein
    8   developed
           prop:  develop.02
            v          * -> 8:0,  developed
            ARG0       * -> 10:1, by Amgen Corp. of Thousand Oaks , Calif. ,
            ARG1       * -> 0:1,  A genetically engineered version
                         -> 4:1,  of the human protein
                       * -> 9:0,  *
    9   *
    10  by
    11  Amgen
           name:  ORG                11-12  Amgen Corp.
    12  Corp.
    13  of
    14  Thousand
           name:  GPE                14-15  Thousand Oaks
    15  Oaks
    16  ,
    17  Calif.
           name:  GPE                17-17  Calif.
    18  ,
    19  recently
    20  has
    21  been
    22  marketed
           sense: market-v.1
           prop:  market.01
            v          * -> 22:0, marketed
            ARGM-TMP   * -> 19:1, recently
            ARG1       * -> 23:0, *-1 -> 0:3, A genetically engineered version of the human protein developed * by Amgen
                                              Corp. of Thousand Oaks , Calif. ,
            ARG0       * -> 24:1, by the Ortho Pharmaceuticals division of Johnson & Johnson
    23  *-1
    24  by
    25  the
    26  Ortho
           name:  ORG                26-27  Ortho Pharmaceuticals
    27  Pharmaceuticals
    28  division
    29  of
    30  Johnson
           name:  ORG                30-32  Johnson & Johnson
    31  &
    32  Johnson
    33  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A competing version of EPO is being developed by Genetics Institute Inc. in Cambridge, Mass.

Treebanked sentence:
--------------------
    A competing version of EPO is being developed *-1 by Genetics Institute Inc. in Cambridge , Mass .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NP (DT A)
                          (VBG competing)
                          (NN version))
                      (PP (IN of)
                          (NP (NNP EPO))))
            (VP (VBZ is)
                (VP (VBG being)
                    (VP (VBN developed)
                        (NP (-NONE- *-1))
                        (PP (IN by)
                            (NP-LGS (NP (NNP Genetics)
                                        (NNP Institute)
                                        (NNP Inc.))
                                    (PP-LOC (IN in)
                                            (NP (NP (NNP Cambridge))
                                                (, ,)
                                                (NP (NNP Mass)))))))))
            (. .)))

Leaves:
-------
    0   A
    1   competing
           sense: compete-v.1
           prop:  compete.01
            v          * -> 1:0,  competing
            ARG0       * -> 2:0,  version
    2   version
    3   of
    4   EPO
    5   is
    6   being
    7   developed
           prop:  develop.02
            v          * -> 7:0,  developed
            ARG1       * -> 8:0,  *-1 -> 0:2, A competing version of EPO
            ARG0       * -> 9:1,  by Genetics Institute Inc. in Cambridge , Mass
    8   *-1
    9   by
    10  Genetics
           name:  ORG                10-12  Genetics Institute Inc.
    11  Institute
    12  Inc.
    13  in
    14  Cambridge
           name:  GPE                14-14  Cambridge
    15  ,
    16  Mass
           name:  GPE                16-16  Mass
    17  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The drug is being used primarily to treat anemias.

Treebanked sentence:
--------------------
    The drug is being used *-1 primarily *PRO* to treat anemias .

Tree:
-----
    (TOP (S (NP-SBJ-1 (DT The)
                      (NN drug))
            (VP (VBZ is)
                (VP (VBG being)
                    (VP (VBN used)
                        (NP (-NONE- *-1))
                        (ADVP (RB primarily))
                        (S-CLR (NP-SBJ (-NONE- *PRO*))
                               (VP (TO to)
                                   (VP (VB treat)
                                       (NP (NNS anemias))))))))
            (. .)))

Leaves:
-------
    0   The
    1   drug
    2   is
    3   being
    4   used
           prop:  use.01
            v          * -> 4:0,  used
            ARG1       * -> 5:0,  *-1 -> 0:1, The drug
            ARGM-ADV   * -> 6:1,  primarily
            ARG2       * -> 7:2,  *PRO* to treat anemias
    5   *-1
    6   primarily
    7   *PRO*
    8   to
    9   treat
           prop:  treat.03
            v          * -> 9:0,  treat
            ARG3       * -> 7:0,  *PRO*
            ARG2       * -> 10:1, anemias
            LINK-PCR   * -> 0:1,  The drug
                       * -> 7:0,  *PRO*
    10  anemias
    11  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A new experiment, reported in this week's New England Journal of Medicine, involved giving injections of Amgen's EPO to
    23 patients who wanted to store units of their own blood.

Treebanked sentence:
--------------------
    A new experiment , reported * in this week 's New England Journal of Medicine , involved *PRO* giving injections of
    Amgen 's EPO to 23 patients who *T*-1 wanted *PRO*-2 to store units of their own blood .

Tree:
-----
    (TOP (S (NP-SBJ (NP (DT A)
                        (JJ new)
                        (NN experiment))
                    (, ,)
                    (VP (VBN reported)
                        (NP (-NONE- *))
                        (PP-LOC (IN in)
                                (NP (NP (NP (DT this)
                                            (NN week)
                                            (POS 's))
                                        (NML (NNP New)
                                             (NNP England))
                                        (NNP Journal))
                                    (PP (IN of)
                                        (NP (NNP Medicine))))))
                    (, ,))
            (VP (VBD involved)
                (S (NP-SBJ (-NONE- *PRO*))
                   (VP (VBG giving)
                       (NP (NP (NNS injections))
                           (PP (IN of)
                               (NP (NP (NNP Amgen)
                                       (POS 's))
                                   (NNP EPO))))
                       (PP-DTV (IN to)
                               (NP (NP (CD 23)
                                       (NNS patients))
                                   (SBAR (WHNP-1 (WP who))
                                         (S (NP-SBJ-2 (-NONE- *T*-1))
                                            (VP (VBD wanted)
                                                (S (NP-SBJ (-NONE- *PRO*-2))
                                                   (VP (TO to)
                                                       (VP (VB store)
                                                           (NP (NP (NNS units))
                                                               (PP (IN of)
                                                                   (NP (PRP$ their)
                                                                       (JJ own)
                                                                       (NN blood)))))))))))))))
            (. .)))

Leaves:
-------
    0   A
    1   new
    2   experiment
    3   ,
    4   reported
           prop:  report.01
            v          * -> 4:0,  reported
            ARG1       * -> 5:0,  *
            ARGM-LOC   * -> 6:1,  in this week 's New England Journal of Medicine
            LINK-PCR   * -> 0:1,  A new experiment
                       * -> 5:0,  *
    5   *
    6   in
    7   this
    8   week
           name:  DATE               8-8    week
    9   's
    10  New
        !  name:  ORG                10-14  New England Journal of Medicine
    11  England
    12  Journal
    13  of
    14  Medicine
    15  ,
    16  involved
           prop:  involve.01
            v          * -> 16:0, involved
            ARG2       * -> 0:2,  A new experiment , reported * in this week 's New England Journal of Medicine ,
            ARG1       * -> 17:2, *PRO* giving injections of Amgen 's EPO to 23 patients who *T*-1 wanted *PRO*-2 to
                                  store units of their own blood
    17  *PRO*
    18  giving
           prop:  give.01
            v          * -> 18:0, giving
            ARG0       * -> 17:0, *PRO*
            ARG1       * -> 19:2, injections of Amgen 's EPO
            ARG2       * -> 24:1, to 23 patients who *T*-1 wanted *PRO*-2 to store units of their own blood
    19  injections
    20  of
    21  Amgen
           name:  ORG                21-21  Amgen
    22  's
    23  EPO
    24  to
    25  23
           name:  CARDINAL           25-25  23
    26  patients
    27  who
    28  *T*-1
    29  wanted
           prop:  want.01
            v          * -> 29:0, wanted
            ARG0       * -> 30:0, *PRO*-2 -> 28:0, *T*-1 -> 27:1, who
            ARG1       * -> 30:2, *PRO*-2 to store units of their own blood
            LINK-SLC   * -> 25:1, 23 patients
                       * -> 30:0, *PRO*-2 -> 28:0, *T*-1 -> 27:1, who
    30  *PRO*-2
    31  to
    32  store
           sense: store-v.1
           prop:  store.01
            v          * -> 32:0, store
            ARG0       * -> 30:0, *PRO*-2 -> 28:0, *T*-1 -> 27:1, who
            ARG1       * -> 33:2, units of their own blood
    33  units
    34  of
    35  their
    36  own
    37  blood
    38  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The patients began receiving EPO injections about a month before their scheduled surgery.

Treebanked sentence:
--------------------
    The patients began *-1 receiving EPO injections about a month before their scheduled surgery .

Tree:
-----
    (TOP (S (NP-SBJ-1 (DT The)
                      (NNS patients))
            (VP (VBD began)
                (S (NP-SBJ (-NONE- *-1))
                   (VP (VBG receiving)
                       (NP (NNP EPO)
                           (NNS injections))
                       (PP-TMP (NP-ADV (QP (IN about)
                                           (DT a))
                                       (NN month))
                               (IN before)
                               (NP (PRP$ their)
                                   (VBN scheduled)
                                   (NN surgery))))))
            (. .)))

Leaves:
-------
    0   The
    1   patients
    2   began
           prop:  begin.01
            v          * -> 2:0,  began
            ARG1       * -> 0:1,  The patients
                         -> 3:2,  *-1 receiving EPO injections about a month before their scheduled surgery
    3   *-1
    4   receiving
           prop:  receive.01
            v          * -> 4:0,  receiving
            ARG0       * -> 3:0,  *-1 -> 0:1, The patients
            ARG1       * -> 5:1,  EPO injections
            ARGM-TMP   * -> 7:3,  about a month before their scheduled surgery
    5   EPO
    6   injections
    7   about
           name:  DATE               7-9    about a month
    8   a
    9   month
    10  before
    11  their
    12  scheduled
           prop:  schedule.01
            v          * -> 12:0, scheduled
            ARG1       * -> 13:0, surgery
    13  surgery
    14  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    They then began donating blood twice a week, receiving an EPO injection each time.

Treebanked sentence:
--------------------
    They then began *-1 donating blood twice a week , *PRO*-2 receiving an EPO injection each time .

Tree:
-----
    (TOP (S (NP-SBJ-1 (PRP They))
            (ADVP-TMP (RB then))
            (VP (VBD began)
                (S (NP-SBJ-2 (-NONE- *-1))
                   (VP (VBG donating)
                       (NP (NN blood))
                       (NP-TMP (PDT twice)
                               (DT a)
                               (NN week))
                       (, ,)
                       (S-ADV (NP-SBJ (-NONE- *PRO*-2))
                              (VP (VBG receiving)
                                  (NP (DT an)
                                      (NNP EPO)
                                      (NN injection))
                                  (NP-TMP (DT each)
                                          (NN time)))))))
            (. .)))

Leaves:
-------
    0   They
    1   then
    2   began
           prop:  begin.01
            v          * -> 2:0,  began
            ARG0       * -> 3:0,  *-1 -> 0:1, They
            ARGM-TMP   * -> 1:1,  then
            ARG1       * -> 3:2,  *-1 donating blood twice a week , *PRO*-2 receiving an EPO injection each time
    3   *-1
    4   donating
           sense: donate-v.1
           prop:  donate.01
            v          * -> 4:0,  donating
            ARG0       * -> 3:0,  *-1 -> 0:1, They
            ARG1       * -> 5:1,  blood
            ARGM-TMP   * -> 6:1,  twice a week
            ARGM-ADV   * -> 10:2, *PRO*-2 receiving an EPO injection each time
            LINK-PCR   * -> 3:0,  *-1 -> 0:1, They
                       * -> 3:0,  *-1 -> 0:1, They
    5   blood
    6   twice
           name:  CARDINAL           6-6    twice
    7   a
    8   week
    9   ,
    10  *PRO*-2
    11  receiving
           prop:  receive.01
            v          * -> 11:0, receiving
            ARG0       * -> 10:0, *PRO*-2 -> 3:0, *-1 -> 0:1, They
            ARG1       * -> 12:1, an EPO injection
            ARGM-TMP   * -> 15:1, each time
            LINK-PCR   * -> 10:0, *PRO*-2 -> 3:0, *-1 -> 0:1, They
                       * -> 10:0, *PRO*-2 -> 3:0, *-1 -> 0:1, They
    12  an
    13  EPO
    14  injection
    15  each
    16  time
    17  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    If tests indicated a low number of red cells, blood was n't taken.

Treebanked sentence:
--------------------
    If tests indicated a low number of red cells , blood was n't taken *-1 .

Tree:
-----
    (TOP (S (SBAR-ADV (IN If)
                      (S (NP-SBJ (NNS tests))
                         (VP (VBD indicated)
                             (NP (NP (DT a)
                                     (JJ low)
                                     (NN number))
                                 (PP (IN of)
                                     (NP (JJ red)
                                         (NNS cells)))))))
            (, ,)
            (NP-SBJ-1 (NN blood))
            (VP (VBD was)
                (RB n't)
                (VP (VBN taken)
                    (NP (-NONE- *-1))))
            (. .)))

Leaves:
-------
    0   If
    1   tests
    2   indicated
           prop:  indicate.01
            v          * -> 2:0,  indicated
            ARG0       * -> 1:1,  tests
            ARG1       * -> 3:2,  a low number of red cells
    3   a
    4   low
    5   number
    6   of
    7   red
    8   cells
    9   ,
    10  blood
    11  was
    12  n't
    13  taken
           prop:  take.01
            v          * -> 13:0, taken
            ARGM-ADV   * -> 0:1,  If tests indicated a low number of red cells
            ARGM-NEG   * -> 12:0, n't
            ARG1       * -> 14:0, *-1 -> 10:1, blood
            LINK-PCR   * -> 14:0, *-1 -> 10:1, blood
                       * -> 14:0, *-1 -> 10:1, blood
    14  *-1
    15  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The EPO-treated patients donated an average of 5.4 units of blood each compared with only 4.1 units donated by a similar
    group of surgical patients who received a placebo injection.

Treebanked sentence:
--------------------
    The EPO - treated patients donated an average of 5.4 units of blood each compared with only 4.1 units donated * by a
    similar group of surgical patients who *T*-1 received a placebo injection .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (ADJP (NNP EPO)
                          (HYPH -)
                          (VBN treated))
                    (NNS patients))
            (VP (VBD donated)
                (NP (NP (DT an)
                        (NN average))
                    (PP (IN of)
                        (NP (NP (CD 5.4)
                                (NNS units))
                            (PP (IN of)
                                (NP (NN blood)))))
                    (NP-ADV (DT each)))
                (PP (VBN compared)
                    (PP (IN with)
                        (NP (NP (QP (RB only)
                                    (CD 4.1))
                                (NNS units))
                            (VP (VBN donated)
                                (NP (-NONE- *))
                                (PP (IN by)
                                    (NP-LGS (NP (DT a)
                                                (JJ similar)
                                                (NN group))
                                            (PP (IN of)
                                                (NP (NP (JJ surgical)
                                                        (NNS patients))
                                                    (SBAR (WHNP-1 (WP who))
                                                          (S (NP-SBJ (-NONE- *T*-1))
                                                             (VP (VBD received)
                                                                 (NP (DT a)
                                                                     (NN placebo)
                                                                     (NN injection))))))))))))))
            (. .)))

Leaves:
-------
    0   The
    1   EPO
    2   -
    3   treated
    4   patients
    5   donated
           sense: donate-v.1
           prop:  donate.01
            v          * -> 5:0,  donated
            ARG0       * -> 0:1,  The EPO - treated patients
            ARG1       * -> 6:2,  an average of 5.4 units of blood each
            ARGM-ADV   * -> 14:1, compared with only 4.1 units donated * by a similar group of surgical patients who
                                  *T*-1 received a placebo injection
    6   an
    7   average
    8   of
    9   5.4
           name:  CARDINAL           9-9    5.4
    10  units
    11  of
    12  blood
    13  each
    14  compared
    15  with
    16  only
           name:  CARDINAL           16-17  only 4.1
    17  4.1
    18  units
    19  donated
           sense: donate-v.1
           prop:  donate.01
            v          * -> 19:0, donated
            ARG1       * -> 20:0, *
            ARG0       * -> 21:1, by a similar group of surgical patients who *T*-1 received a placebo injection
            LINK-PCR   * -> 16:2, only 4.1 units
                       * -> 20:0, *
    20  *
    21  by
    22  a
    23  similar
    24  group
    25  of
    26  surgical
    27  patients
    28  who
    29  *T*-1
    30  received
           prop:  receive.01
            v          * -> 30:0, received
            ARG0       * -> 29:0, *T*-1 -> 28:1, who
            ARG1       * -> 31:1, a placebo injection
            LINK-SLC   * -> 26:1, surgical patients
                       * -> 29:0, *T*-1 -> 28:1, who
    31  a
    32  placebo
    33  injection
    34  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The volume of red cells donated by the EPO-treated patients was 41 % higher per donor, the research team representing a
    number of hospitals and blood banks reported.

Treebanked sentence:
--------------------
    The volume of red cells donated * by the EPO - treated patients was 41 % higher per donor , the research team
    representing a number of hospitals and blood banks reported 0 *T*-1 .

Tree:
-----
    (TOP (S (S-TPC-1 (NP-SBJ (NP (DT The)
                                 (NN volume))
                             (PP (IN of)
                                 (NP (NP (JJ red)
                                         (NNS cells))
                                     (VP (VBN donated)
                                         (NP (-NONE- *))
                                         (PP (IN by)
                                             (NP-LGS (DT the)
                                                     (ADJP (NNP EPO)
                                                           (HYPH -)
                                                           (VBN treated))
                                                     (NNS patients)))))))
                     (VP (VBD was)
                         (ADVP-PRD (NP (CD 41)
                                       (NN %))
                                   (JJR higher))
                         (PP (IN per)
                             (NP (NN donor)))))
            (, ,)
            (NP-SBJ (NP (DT the)
                        (NN research)
                        (NN team))
                    (VP (VBG representing)
                        (NP (NP (DT a)
                                (NN number))
                            (PP (IN of)
                                (NP (NP (NNS hospitals))
                                    (CC and)
                                    (NP (NN blood)
                                        (NNS banks)))))))
            (VP (VBD reported)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-1))))
            (. .)))

Leaves:
-------
    0   The
    1   volume
    2   of
    3   red
    4   cells
    5   donated
           sense: donate-v.1
           prop:  donate.01
            v          * -> 5:0,  donated
            ARG1       * -> 6:0,  *
            ARG0       * -> 7:1,  by the EPO - treated patients
            LINK-PCR   * -> 3:1,  red cells
                       * -> 6:0,  *
    6   *
    7   by
    8   the
    9   EPO
    10  -
    11  treated
    12  patients
    13  was
           prop:  be.01
            v          * -> 13:0, was
            ARG1       * -> 0:2,  The volume of red cells donated * by the EPO - treated patients
            ARG2       * -> 14:2, 41 % higher
            ARGM-PRD   * -> 17:1, per donor
    14  41
           name:  PERCENT            14-15  41 %
    15  %
    16  higher
    17  per
    18  donor
    19  ,
    20  the
    21  research
    22  team
    23  representing
           prop:  represent.01
            v          * -> 23:0, representing
            ARG0       * -> 20:1, the research team
            ARG1       * -> 24:2, a number of hospitals and blood banks
    24  a
    25  number
    26  of
    27  hospitals
    28  and
    29  blood
    30  banks
    31  reported
           prop:  report.01
            v          * -> 31:0, reported
            ARG0       * -> 20:2, the research team representing a number of hospitals and blood banks
            ARG1       * -> 32:1, 0 *T*-1
    32  0
    33  *T*-1
    34  .

